June this year ended with a record delivery of products for injection in the US market. Thus, on Wednesday, June 29, six trucks with injectable antiinfectives with the label 'made by Antibiotice for the U.S.A.' went to the Port of Constanta.[Attachment]

Our two antiinfective products, Nafcillin 1 g and 2 g and Ampicillin 500 mg, 1g and 2g will go overseas, to the American patients from hospitals. In addition to these products, the procedure for authorizing in the US market a new Antibiotice product, Ampicillin and sulbactam 1.5 g and 3 g, powder for solution for injection/infusion in two doses was completed.

This is the largest delivery of finished products in the US, a strategic market for Antibiotice, from the beginning of 2016. With this delivery, the export value of finished products and Nystatin in the American market, in the first semester reached 3.4 million USD, a double value as compared to that achieved in the first half of 2015.

Antibiotice SA published this content on 07 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 07 July 2016 07:10:02 UTC.

Original documenthttp://www.antibiotice.ro/en/noutati/livrare-record-de-injectabile-produse-de-antibiotice-pe-piata-sua/

Public permalinkhttp://www.publicnow.com/view/7EE494254BF781EB68E233812C8C64DEFF6B6E81